Literature DB >> 20554802

Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.

Sung-Ung Moon1, Hyung-Hwan Kim, Tong-Soo Kim, Kyung-Mi Choi, Chang-Mi Oh, Yong-Joo Ahn, Seo-Kyoung Hwang, Youngjoo Sohn, E-Hyun Shin, Hyuck Kim, Hyeong-Woo Lee.   

Abstract

To develop a vaccine to block the transmission of vivax malaria, the gene encoding the ookinete surface protein Pvs25 was cloned from a Korean malaria patient. The Pvs25 gene was 660 bp long, encoding 219 amino acids. It was subcloned into the expression vector pQE30 and expressed in Escherichia coli. The expressed recombinant protein, named rPvs25, showed a molecular mass of approximately 25 kDa by SDS-PAGE analysis. An anti-rPvs25 monoclonal antibody produced in BALB/c mice was able to inhibit sporozoite development in the mosquito Anopheles sinensis, which is known as the malaria transmission vector in the Republic of Korea. In addition, rPvs25 produced a relatively high antibody titer in BALB/c mice that lasted for more than 6 months. Based on these results, we suggest that recombinant Pvs25 could be a useful antigen in the development of a vaccine to prevent local malaria transmission in the Republic of Korea.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554802      PMCID: PMC2916255          DOI: 10.1128/CVI.00101-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

1.  Sequence diversity in rodent malaria of the Pfs28 ookinete surface antigen homologs.

Authors:  D Taylor; N Cloonan; V Mann; Q Cheng; A Saul
Journal:  Mol Biochem Parasitol       Date:  2000-10       Impact factor: 1.759

2.  Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria.

Authors:  Lina Wang; Lukasz Kedzierski; Steven L Wesselingh; Ross L Coppel
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Harinasuta; P Suntharasamai; C Viravan
Journal:  Lancet       Date:  1965-10-02       Impact factor: 79.321

Review 4.  Malaria in Korea.

Authors:  Y H Paik; H I Ree; J C Shim
Journal:  Jpn J Exp Med       Date:  1988-04

Review 5.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden.

Authors:  J G Breman
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.

Authors:  Sedigheh Zakeri; Sepand Razavi; Navid Dinparast Djadid
Journal:  Acta Trop       Date:  2008-09-30       Impact factor: 3.112

7.  Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.

Authors:  Matthias H Kapturczak; Clive Wasserfall; Todd Brusko; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson; Anupam Agarwal
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Detection of vivax malaria sporozoites naturally infected in Anopheline mosquitoes from endemic areas of northern parts of Gyeonggi-do (Province) in Korea.

Authors:  Hyeong Woo Lee; E-Hyun Shin; Shin Hyeong Cho; Hee Il Lee; Chung Lim Kim; Wook Gyo Lee; Sung Ung Moon; Jong Soo Lee; Won Ja Lee; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2002-06       Impact factor: 1.341

9.  A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

Authors:  D C Kaslow; I A Quakyi; C Syin; M G Raum; D B Keister; J E Coligan; T F McCutchan; L H Miller
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

10.  Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.

Authors:  Jetsumon Sattabongkot; Takafumi Tsuboi; Hajime Hisaeda; Mayumi Tachibana; Nantavadee Suwanabun; Thanaporn Rungruang; Ya-Ming Cao; Anthony W Stowers; Jeeraphat Sirichaisinthop; Russell E Coleman; Motomi Torii
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345

View more
  4 in total

1.  Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar.

Authors:  Tong-Soo Kim; Hyung-Hwan Kim; Jung-Yeon Kim; Yoon Kong; Byoung-Kuk Na; Khin Lin; Sung-Ung Moon; Yeon-Joo Kim; Myoung-Hee Kwon; Youngjoo Sohn; Hyuck Kim; Hyeong-Woo Lee
Journal:  Malar J       Date:  2011-08-06       Impact factor: 2.979

2.  Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China.

Authors:  Hui Feng; Li Zheng; Xiaotong Zhu; Gege Wang; Yanyan Pan; Ying Li; Yimei Yang; Yahui Lin; Liwang Cui; Yaming Cao
Journal:  Parasit Vectors       Date:  2011-11-28       Impact factor: 3.876

Review 3.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

4.  Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates.

Authors:  Jung-Mi Kang; Hye-Lim Ju; Sung-Ung Moon; Pyo-Yun Cho; Young-Yil Bahk; Woon-Mok Sohn; Yun-Kyu Park; Seok Ho Cha; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2013-04-30       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.